Mark A. Goldberg
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Physiology top 2%
- Hematology top 0.5%
- Genetics top 2%
- Co-authors
- Andrew P. LevyH. Franklin BunnNina S. LevyThomas J. SchneiderScott A. WegnerWilliam G. KaelinOthon IliopoulosCong Jiang
- Topics
- Cancer, Hypoxia, and Metabolism (18 papers)Erythropoietin and Anemia Treatment (10 papers)Pharmacological Effects and Toxicity Studies (8 papers)
- Cited by
- Cancer ResearchHematologyGenetics
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark A. Goldberg
96 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Molecular Biology 4.3k
- Cancer Research 3.5k
- Physiology 1.3k
- Hematology 1.3k
- Genetics 957
Countries citing papers authored by Mark A. Goldberg
This map shows the geographic impact of Mark A. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Goldberg more than expected).
Fields of papers citing papers by Mark A. Goldberg
This network shows the impact of papers produced by Mark A. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Goldberg. The network helps show where Mark A. Goldberg may publish in the future.
Co-authorship network of co-authors of Mark A. Goldberg
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Goldberg. A scholar is included among the top collaborators of Mark A. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Goldberg. Mark A. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 54 | |
| 4 | 34 | |
| 5 | 259 | |
| 6 | 66 | |
| 7 | 39 | |
| 8 | 2 | |
| 9 | 179 | |
| 10 | 12 | |
| 11 | 8 | |
| 12 | 92 | |
| 13 | 10 | |
| 14 | 156 | |
| 15 | Regulation of erythropoietin production. | 30 |
| 16 | 241 | |
| 17 | 19 | |
| 18 | 24 | |
| 19 | 101 | |
| 20 | 15 |
About Mark A. Goldberg
Mark A. Goldberg is a scholar working on Cancer Research, Hematology and Clinical Biochemistry, having authored 97 papers that have together received 9.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (18 papers), Erythropoietin and Anemia Treatment (10 papers) and Pharmacological Effects and Toxicity Studies (8 papers). The work is most often cited by research in Cancer Research (3.5k citations), Hematology (1.3k citations) and Genetics (827 citations). Mark A. Goldberg has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrew P. Levy, H. Franklin Bunn, Nina S. Levy, Thomas J. Schneider, Scott A. Wegner, William G. Kaelin, Othon Iliopoulos, Cong Jiang, Eric Huang and H. Franklin Bunn. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.